{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:05:28Z","timestamp":1785722728058,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.mayocp.2021.02.019","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T08:33:48Z","timestamp":1627893228000},"page":"2029-2039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Autoimmune Encephalitis\u2013Related Seizures and Epilepsy: Diagnostic and Therapeutic Approaches"],"prefix":"10.1016","volume":"96","author":[{"given":"Baibing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sebastian","family":"Lopez Chiriboga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9887-0917","authenticated-orcid":false,"given":"Joseph I.","family":"Sirven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9318-3947","authenticated-orcid":false,"given":"Anteneh M.","family":"Feyissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.mayocp.2021.02.019_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.mayocp.2021.02.019_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A\u00a0clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2021.02.019_bib4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"issue":"18","key":"10.1016\/j.mayocp.2021.02.019_bib5","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0000000000002637","article-title":"The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies","volume":"86","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2021.02.019_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.mayocp.2021.02.019_bib7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.02.019_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","article-title":"Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies","volume":"13","author":"Petit-Pedrol","year":"2014","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.02.019_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.02.019_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"issue":"pt 8","key":"10.1016\/j.mayocp.2021.02.019_bib11","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.mayocp.2021.02.019_bib12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","article-title":"Clinical spectrum of encephalitis associated with antibodies against the \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature","volume":"72","author":"Joubert","year":"2015","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.02.019_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"issue":"22","key":"10.1016\/j.mayocp.2021.02.019_bib14","doi-asserted-by":"crossref","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis with mGluR5 antibodies: symptoms and antibody effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology"},{"issue":"pt 8","key":"10.1016\/j.mayocp.2021.02.019_bib15","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes [published correction appears in Brain. 2014;137(pt 12):e315]","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"issue":"pt 6","key":"10.1016\/j.mayocp.2021.02.019_bib16","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.mayocp.2021.02.019_bib17","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/epi.13834","article-title":"Prevalence and outcome of late-onset seizures due to autoimmune etiology: a prospective observational population-based cohort study","volume":"58","author":"von Podewils","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.mayocp.2021.02.019_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fimmu.2017.00395","article-title":"Advances in autoimmune epilepsy associated with antibodies, their potential pathogenic molecular mechanisms, and current recommended immunotherapies","volume":"8","author":"Fang","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.02.019_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/epi.14662","article-title":"A\u00a0mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis","volume":"60","author":"Taraschenko","year":"2019","journal-title":"Epilepsia"},{"issue":"18","key":"10.1016\/j.mayocp.2021.02.019_bib20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mayocp.2021.02.019_bib21","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1212\/NXI.0000000000000849","article-title":"Clinically based score predicting cryptogenic NORSE at the early stage of status epilepticus","volume":"7","author":"Yanagida","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.mayocp.2021.02.019_bib22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.02.019_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/epi.14649","article-title":"Antibody prevalence in epilepsy and encephalopathy score: increased specificity and applicability","volume":"60","author":"Dubey","year":"2019","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.mayocp.2021.02.019_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.26013","article-title":"Antibodies contributing to focal epilepsy signs and symptoms score","volume":"89","author":"de Bruijn","year":"2021","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.02.019_bib25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"issue":"18","key":"10.1016\/j.mayocp.2021.02.019_bib26","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","article-title":"Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy","volume":"82","author":"Toledano","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mayocp.2021.02.019_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jnnp-2020-325011","article-title":"Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies","volume":"92","author":"McGinty","year":"2021","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.mayocp.2021.02.019_bib28","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1212\/NXI.0000000000000353","article-title":"Antiepileptic drug therapy in patients with autoimmune epilepsy","volume":"4","author":"Feyissa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"10.1016\/j.mayocp.2021.02.019_bib29","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/epi.16282","article-title":"Seizure specificities in patients with antibody-mediated autoimmune encephalitis","volume":"60","author":"Vogrig","year":"2019","journal-title":"Epilepsia"},{"issue":"19","key":"10.1016\/j.mayocp.2021.02.019_bib30","doi-asserted-by":"crossref","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"92","author":"de Bruijn","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mayocp.2021.02.019_bib31","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/epi.13797","article-title":"Predictive models in the diagnosis and treatment of autoimmune epilepsy","volume":"58","author":"Dubey","year":"2017","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.mayocp.2021.02.019_bib32","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/acn3.51212","article-title":"Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration","volume":"7","author":"Herdlevaer","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.mayocp.2021.02.019_bib33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-014-0160-0","article-title":"Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures","volume":"11","author":"Greenlee","year":"2014","journal-title":"J\u00a0Neuroinflammation"},{"issue":"3","key":"10.1016\/j.mayocp.2021.02.019_bib34","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1212\/NXI.0000000000000696","article-title":"Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment [published correction appears in Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e733]","volume":"7","author":"Mu\u00f1oz-Lopetegi","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"10.1016\/j.mayocp.2021.02.019_bib35","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/81.9.1207","article-title":"Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction","volume":"81","author":"Pittock","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2021.02.019_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ane.12799","article-title":"Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies","volume":"137","author":"Falip","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.mayocp.2021.02.019_bib37","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1212\/WNL.0000000000008785","article-title":"Hashimoto encephalopathy in the 21st century","volume":"94","author":"Mattozzi","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2021.02.019_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.mayocp.2021.02.019_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/practneurol-2019-002494","article-title":"Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2","volume":"20","author":"Michael","year":"2020","journal-title":"Pract Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.02.019_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2016-314758","article-title":"Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies","volume":"88","author":"Lang","year":"2017","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"16","key":"10.1016\/j.mayocp.2021.02.019_bib41","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mayocp.2021.02.019_bib42","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1212\/NXI.0000000000000396","article-title":"Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy","volume":"4","author":"Iizuka","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"10.1016\/j.mayocp.2021.02.019_bib43","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jamaneurol.2014.463","article-title":"Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy","volume":"71","author":"Irani","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.02.019_bib44","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1212\/NXI.0000000000000633","article-title":"Anti-NMDAR encephalitis: a single-center, longitudinal study in China","volume":"7","author":"Xu","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"17","key":"10.1016\/j.mayocp.2021.02.019_bib45","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1212\/WNL.0000000000007322","article-title":"New onset refractory status epilepticus research: what is on the horizon?","volume":"92","author":"Gofton","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mayocp.2021.02.019_bib46","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.mayocp.2021.02.019_bib47","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp-2014-309388","article-title":"Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mayocp.2021.02.019_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.12.010","article-title":"Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies","volume":"129","author":"Carre\u00f1o","year":"2017","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.mayocp.2021.02.019_bib49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/epi4.12395","article-title":"Brain-responsive neurostimulation treatment in patients with GAD65 antibody-associated autoimmune mesial temporal lobe epilepsy","volume":"5","author":"Feyissa","year":"2020","journal-title":"Epilepsia Open"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621001750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619621001750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:35:09Z","timestamp":1758418509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619621001750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0025619621001750"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.02.019","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Encephalitis\u2013Related Seizures and Epilepsy: Diagnostic and Therapeutic Approaches","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}